ClinicalTrials.gg
Sign In

Keloid clinical trials

The registry lists 138 studies for Keloid across more than 10 countries. 26 are recruiting or about to start. 109 of them are mainly about Keloid (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Keloid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
68
Status unknown
24
Recruiting
13
Not yet recruiting
12
Terminated
10
Withdrawn
6

Phase

Phase 2
37
Phase 1
19
Phase 4
17
Phase 3
11
Early Phase 1
4

Where

United States
55
China
7
Egypt
7
Thailand
5
France
4
Indonesia
4

Who runs them

Tirgan, Michael H., M.D. (8) · University of Michigan (3) · Renovo (3) · Amsterdam UMC, location VUmc (3) · Mahidol University (3) · Capstone Therapeutics (2) · University of Miami (2) · Northwestern University (2)

What is being tested here

Drugs under test in Keloid studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Triamcinolone3111
Triamcinolone Acetonide308
Botulinum Toxins212
RNA, Small Interfering101
Drugs, Chinese Herbal101
Polidocanol101
Insulin101
PF-06651600101
Botulinum toxin type A004
Fluorouracil003

Drug classes tested here Corticosteroids 3 open

Coming up

3phase 3 studies under way
6studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6, phase 3 first

Who these studies take

Of the 13 Keloid studies recruiting now, 7 (54%) set no upper age limit and 5 (38%) stop at 75 or younger. 2 (15%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (23%) take healthy volunteers.

Recruiting studies that take each age, of 13
AgeWomenMen
101 (8%)1 (8%)
1812 (92%)12 (92%)
3013 (100%)13 (100%)
4013 (100%)13 (100%)
5013 (100%)13 (100%)
6511 (85%)11 (85%)
7510 (77%)10 (77%)
857 (54%)7 (54%)

Across all 138 studies, recruiting or not: 33% stop at 75 or younger and 25% at 65; 25% take children; 4% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Keloid studies take

Of 20 interventional studies with no phase under Keloid, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo7–36 · 20 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 138. Browse all 138 → or search them.